Uncovering the zoological host that first transmitted the virus to humans could inform factors relevant to this pandemic—and the next one.
The FDA gives Moderna the green light to increase vaccine vials by 40%.
The co-lead investigators discuss the upcoming first study to assess long-term outcomes on MIS-C patients.
This further emphasizes the higher rate of mortality in COVID-19 compared to influenza.